Injured by COVID Vaccines in the U.S. will not receive Compensation
commentaries by Robert Gorter, MD, PhD.
January 27th, 2021
A new article published in the New England Journal of Medicine outlines why those injured by the COVID-19 vaccine won’t be eligible for compensation from the Vaccine Injury Compensation Program (VICP) while COVID is still an “emergency.”
Is a COVID-19 vaccine requirement for travel, school attendance, employment, and other freedoms, unethical? Should freedom of choice always remain? Does the vaccine have the ability to stop transmission and infection?
Many countries have a vaccine injury compensation program. Canada, for example, recently created one just prior to the rollout of the COVID-19 vaccine. These programs compensate people who have been and are injured by one or more vaccines, which in some cases have been known to cause hospitalizations due to severe adverse reactions, permanent disabilities, and even death. Federal health regulatory agencies claim these are extremely rare events, that approximately one in a million people suffer these kinds of injuries. This may be very true, but no statistics, information, or sources are provided, and vaccine injury reporting systems, like the Vaccine Adverse Events Reporting System (VAERS) in the United States, for example, only capture an estimated one percent of vaccine injuries because the majority of them are believed to be unreported.
There is information out there that that claims otherwise. For example, an HHS pilot study conducted by the Federal Agency for Health Care Research found that 1 in every 39 vaccines in the United States caused some type of injury, which is a shocking comparison to the 1 in every million claims. The Vaccine Injury Compensation Program (VICP) protects the vaccine manufacturers (pharmaceutical companies) from any liability, and the money comes out of the taxpayer’s pocket. In the United States, the VICP has paid out more than $4 billion dollars due to vaccine injuries. Since 2015, the program has paid out an average total of $216 million to an average of 615 claimants each year.
When it comes to the COVID-19 vaccine,